Clinical Trials

Showing trials with last updates posted in 2010.

NCT00410657 | COMPLETED | PHASE2
53 participants

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2010-05-14
Start Date:
2006-07-31
Completion:
2006-11-30
Conditions
  • Breast Cancer
  • Chronic Myeloproliferative Disorders
  • Gestational Trophoblastic Tumor
  • Graft Versus Host Disease
  • Leukemia
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Diseases
  • Neuroblastoma
  • Ovarian Cancer
  • Testicular Germ Cell Tumor
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT00346359 | COMPLETED | PHASE2
40 participants

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2010-05-14
Start Date:
2006-03-31
Conditions
  • Chronic Myeloproliferative Disorders
  • Graft Versus Host Disease
  • Leukemia
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Diseases
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
No Results Yet
NCT00054340 | COMPLETED | PHASE1/PHASE2

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2010-05-14
Start Date:
2002-10-31
Conditions
  • Chronic Myeloproliferative Disorders
  • Graft Versus Host Disease
  • Leukemia
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Diseases
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page